Published in Biomed Res Int on December 23, 2013
Clinical pharmacology of paracetamol in neonates: a review. Curr Ther Res Clin Exp (2014) 0.79
Thromboxane A(2) receptor stimulation promotes closure of the rat ductus arteriosus through enhancing neointima formation. PLoS One (2014) 0.76
Ibuprofen Versus Indomethacin for Medical Closure of the Patent Arterial Duct: A Pooled Analysis by Route of Administration. Cureus (2015) 0.75
Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med (2001) 3.77
Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology (2012) 3.35
Early surgical ligation versus a conservative approach for management of patent ductus arteriosus that fails to close after indomethacin treatment. J Pediatr (2010) 3.13
Patent ductus arteriosus: lack of evidence for common treatments. Arch Dis Child Fetal Neonatal Ed (2007) 2.88
Increased indomethacin dosing for persistent patent ductus arteriosus in preterm infants: a multicenter, randomized, controlled trial. J Pediatr (2008) 2.72
Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr (1983) 2.65
Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child (1990) 2.59
Oral ibuprofen versus intravenous ibuprofen or intravenous indomethacin for the treatment of patent ductus arteriosus in preterm infants: a systematic review and meta-analysis. Neonatology (2012) 2.10
Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr (2007) 2.07
Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res (2000) 1.94
Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease and management. N Engl J Med (1972) 1.93
Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants. J Pediatr (1981) 1.89
The role of patent ductus arteriosus ligation in bronchopulmonary dysplasia: reexamining a randomized controlled trial. J Pediatr (2009) 1.82
A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med (1989) 1.64
Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias. J Pediatr (2012) 1.61
Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics (2007) 1.61
Early versus late indomethacin treatment for patent ductus arteriosus in premature infants with respiratory distress syndrome. J Pediatr (2001) 1.61
Timing of patent ductus arteriosus treatment and respiratory outcome in premature infants: a double-blind randomized controlled trial. J Pediatr (2012) 1.58
Does Ibuprofen increase neonatal hyperbilirubinemia? Pediatrics (2009) 1.58
Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics (2006) 1.55
Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet (2004) 1.55
Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet (2004) 1.53
Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr (1978) 1.53
High-dose ibuprofen for patent ductus arteriosus in extremely preterm infants: a randomized controlled study. Clin Pharmacol Ther (2011) 1.52
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (2002) 1.51
Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight preterm infants with patent ductus arteriosus. J Pediatr (2010) 1.51
Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol (2010) 1.50
Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed (1996) 1.49
Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation. Pediatrics (2005) 1.49
Effect of persistent patent ductus arteriosus on mortality and morbidity in very low-birthweight infants. Acta Paediatr (2012) 1.47
Patent ductus arteriosus ligation and post-operative hemodynamic instability: case report and framework for enhanced neonatal care. Indian J Pediatr (2010) 1.44
Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed (2005) 1.43
Treatment of patent ductus arteriosus. Semin Neonatol (2003) 1.43
Effects of patent ductus arteriosus on left ventricular output and organ blood flows in preterm infants with respiratory distress syndrome treated with surfactant. J Pediatr (1994) 1.42
Risk factors for chronic lung disease in the surfactant era: a North Carolina population-based study of very low birth weight infants. North Carolina Neonatologists Association. Pediatrics (1999) 1.41
Early echocardiographic prediction of symptomatic patent ductus arteriosus in preterm infants undergoing mechanical ventilation. J Pediatr (1995) 1.39
Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics (2011) 1.37
Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study. J Pediatr Gastroenterol Nutr (2005) 1.34
Towards rational management of the patent ductus arteriosus: the need for disease staging. Arch Dis Child Fetal Neonatal Ed (2007) 1.34
Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr (1999) 1.31
Outcome of children in the indomethacin intraventricular hemorrhage prevention trial. Pediatrics (2000) 1.30
Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med (1982) 1.30
Is surgical ligation of patent ductus arteriosus necessary? The Western Australian experience of conservative management. Arch Dis Child Fetal Neonatal Ed (2005) 1.30
Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev (2010) 1.29
Ductal shunting, high pulmonary blood flow, and pulmonary hemorrhage. J Pediatr (2000) 1.27
The pharmacologic closure of the patent ductus arteriosus. Semin Fetal Neonatal Med (2004) 1.27
Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics (2009) 1.26
Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics (2009) 1.25
Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr (2004) 1.24
Network meta-analysis of indomethacin versus ibuprofen versus placebo for PDA in preterm infants. Arch Dis Child Fetal Neonatal Ed (2010) 1.24
Comparison of hydroperoxide initiator requirements for the cyclooxygenase activities of prostaglandin H synthase-1 and -2. J Biol Chem (1995) 1.23
Review of studies evaluating ductal patency in the premature infant. J Pediatr (1993) 1.22
Patent ductus arteriosus in micropreemies and full-term infants: the relative merits of surgical ligation versus indomethacin treatment. J Pediatr Surg (2003) 1.21
Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (2006) 1.17
Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr (1984) 1.17
Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J Pediatr (1997) 1.16
Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus? Eur J Pediatr (2009) 1.16
Day case ligation of patent ductus arteriosus in preterm infants: a 10 year review. Arch Dis Child (1991) 1.13
Effect of indomethacin on superior mesenteric artery blood flow velocity in preterm infants. J Pediatr (1990) 1.13
Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2003) 1.13
Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (2011) 1.12
Patent ductus arteriosus in premature infants. Med J Aust (1963) 1.12
Unilateral vocal cord paralysis following patent ductus arteriosus ligation in extremely low-birth-weight infants. Arch Otolaryngol Head Neck Surg (2008) 1.12
Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins (1989) 1.11
Optimal management of patent ductus arteriosus in the neonate weighing less than 800 g. J Pediatr Surg (1993) 1.10
Management of patent ductus arteriosus: a comparison of operative v pharmacologic treatment. J Pediatr Surg (1987) 1.08
Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis. J Perinatol (2010) 1.08
Ductus arteriosus ligation and alveolar growth in preterm baboons with a patent ductus arteriosus. Pediatr Res (2008) 1.07
Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants. Pediatrics (1988) 1.07
Cardiocirculatory effects of patent ductus arteriosus in extremely low-birth-weight infants with respiratory distress syndrome. Pediatr Int (2003) 1.07
Patent ductus arteriosus: are current neonatal treatment options better or worse than no treatment at all? Semin Perinatol (2012) 1.07
Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants. Arch Dis Child Fetal Neonatal Ed (1999) 1.06
Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2003) 1.06
Doppler assessment of pulmonary artery pressure during recovery from hyaline membrane disease. Arch Dis Child (1991) 1.05
Prophylactic indomethacin: factors determining permanent ductus arteriosus closure. J Pediatr (2000) 1.05
A different first-choice drug in the medical management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med (2013) 1.04
Postoperative cardiorespiratory instability following ligation of the preterm ductus arteriosus is related to early need for intervention. J Perinatol (2008) 1.03
Patent ductus arteriosus and cerebral circulation in preterm infants. Dev Med Child Neurol (1990) 1.03
Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev (2008) 1.02
Persistent Doppler flow predicts lack of response to multiple courses of indomethacin in premature infants with recurrent patent ductus arteriosus. Pediatrics (2003) 0.99
An alternative drug (paracetamol) in the management of patent ductus arteriosus in ibuprofen-resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed (2012) 0.98
Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation. Pediatr Cardiol (2013) 0.98
Pharmacokinetics and protein binding of intravenous ibuprofen in the premature newborn infant. Acta Paediatr (1997) 0.97
Indomethacin-associated bowel perforations: a study of possible risk factors. J Pediatr Surg (1999) 0.97
Surgical closure of patent ductus arteriosus in preterm low birth weight infants. Congenit Heart Dis (2009) 0.97
The ductus arteriosus rarely requires treatment in infants > 1000 grams. Am J Perinatol (2008) 0.97
N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed (2008) 0.96
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev (2010) 0.96
Effect of prolonged indomethacin therapy on renal function and selected vasoactive hormones in very-low-birth-weight infants with symptomatic patent ductus arteriosus. J Pediatr (1983) 0.96
Dose-finding study of ibuprofen in patent ductus arteriosus using the continual reassessment method. J Clin Pharm Ther (2005) 0.95
Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants. J Perinatol (2009) 0.94
Should all newborns who undergo patent ductus arteriosus ligation be examined for vocal fold mobility? Laryngoscope (2009) 0.94
Effects of prostaglandins and indomethacin on cerebral blood flow and cerebral oxygen consumption of conscious newborn piglets. Dev Pharmacol Ther (1990) 0.94
Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. Cochrane Database Syst Rev (2008) 0.94
B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus. J Pediatr (2010) 0.93
A randomized, double-blind, placebo-controlled trial on intravenous ibuprofen L-lysine for the early closure of nonsymptomatic patent ductus arteriosus within 72 hours of birth in extremely low-birth-weight infants. Am J Perinatol (2008) 0.93
Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants. Cochrane Database Syst Rev (2008) 0.92
Video-assisted thoracoscopic surgery for patent ductus arteriosus in low birth weight neonates and infants. Pediatrics (1999) 0.92
Managing the patent ductus arteriosus in the premature neonate: a new look at what we thought we knew. Semin Perinatol (2012) 0.92
Scoliosis in patients with aortic coarctation and patent ductus arteriosus: does standard posterolateral thoracotomy play a role in the development of the lateral curve of the spine? Pediatr Cardiol (2009) 0.92